Delpor, Inc.

📍 Brisbane, United States🗓 Founded 2009👥 9 employees💰 Last funded Aug 2018
Biotechnology🌐 delpor.com
Website LinkedIn
Delpor is a clinical stage life sciences company that utilizes innovative drug-delivery technologies in order to develop once-yearly therapies for chronic conditions. The Company’s lead product is a 6-12-month formulation of Risperidone (drug/device combination product) for the treatment of schizophrenia. Delpor is also pursuing 6-12 month formulations of other drugs targeting CNS conditions including Neuromuscular Diseases, Neurodegenerative Diseases, Addiction, and other disorders.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2009
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Italy
1
Frequently asked questions
Who invested in Delpor, Inc.?
Delpor, Inc. has 1 investors on record on gritt.io and 1 late-stage investors.
When did Delpor, Inc. last raise funding?
The most recent investment in Delpor, Inc. recorded on gritt.io was in August 2018.
When was Delpor, Inc. founded?
Delpor, Inc. was founded in 2009.
What industry is Delpor, Inc. in?
Delpor, Inc. operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Delpor, Inc. based?
Delpor, Inc. is headquartered in Brisbane, United States.